Medical
Capstan Medical raised $110 million in a Series C funding round.
A dated step forward on the record
What the source says
“The startup raised $110 million in its Series C round last year.”
What it means
Money came before any patient result on our record. The $110 million Series C was raised in 2024, a year before the company reported its first two cases in Chile. Funding says little about how far a robot has got, so this entry sets no stage by itself. So far, the later milestones show the work moving from first cases abroad to a U.S. study.
Compass robotic system, from Capstan Medical, is at stage 3 of 5 on our ladder: pilot. Its stage is set by other milestones on its record; this one adds to the history.
Human help: A surgeon in the operating room controls it; it doesn't operate on its own.
Written with AI from our record of Compass robotic system and checked against it: every figure appears in that record.
More on Compass robotic system
- Capstan Medical said its investigational robot was used in the first U.S. transcatheter mitral valve replacement, performed on Nov. 9 in Cincinnati.
- Capstan Medical said a surgeon in Chile had completed the first successful catheter-delivered mitral valve replacements in two patients using its implant and robotics system.
